Beyond Meat forecasts upbeat quarterly revenue on steady international demand
Beyond Meat forecast third-quarter revenue of $60 million to $65 million, above Wall Street’s $62.2 million estimate, citing resilient international demand. Adjusted loss was 9 cents per share. Q2 revenue was $68.8 million. International retail sales rose 16.5% year over year, while U.S. sales fell 14.4%. Shares fell 3% after results, according to Reuters.
How this was made
The 30-second read
Why it matters
The company’s third-quarter revenue forecast and international retail growth provide a near-term fundamental catalyst, but the U.S. sales contraction and the stock’s extended-trading drop temper the bullish read-through.
Market read
Traders can reassess BYND’s near-term demand trajectory using the explicit revenue range and segment performance, which may drive follow-through or fade depending on how investors interpret the U.S. decline.
What to watch
Investors may be underweighting profitability trajectory and whether new product rollouts (e.g., protein drinks) translate into sustained gross margin improvement, not just revenue.
Background
Beyond Meat has struggled to sustain early enthusiasm for its plant-based products and is trying to re-accelerate demand with new offerings.
Ticker impact
Beyond Meat guided third-quarter revenue to $60 million to $65 million, with international retail sales up 16.5% year over year.
Shares may see continued post-earnings volatility, with upside bias if investors focus on international resilience versus U.S. weakness.
The article provides explicit revenue guidance and segment growth figures, but also notes the stock is down 3% in extended trading, implying the market is still skeptical about the overall turnaround.
Market effects
Signals plant-based food demand resilience outside the U.S., which can influence read-across sentiment for other alternative protein names.
International segment strength may shift investor focus toward non-U.S. growth drivers for consumer staples/food tech.
International demand resilience supports the broader narrative that alternative proteins can scale beyond domestic markets.
Counterpoint
The guidance midpoint is only modestly above consensus, and the U.S. sales decline suggests the core turnaround is not yet working.
Key entities
- companyBeyond Meat
Plant-based food maker forecasting third-quarter revenue above estimates, with international retail sales growth offsetting U.S. weakness.
